Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Becton, Dickinson and Company    BDX

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
232.9(c) 231.87(c) 228.48(c) 229.29(c) 227.47(c) Last
1 439 467 1 255 875 1 496 456 2 314 373 1 628 132 Volume
-0.24% -0.44% -1.46% +0.35% -0.79% Change
More quotes
Financials (USD)
Sales 2021 19 092 M - -
Net income 2021 2 408 M - -
Net Debt 2021 11 614 M - -
P/E ratio 2021 24,7x
Yield 2021 1,62%
Sales 2022 19 325 M - -
Net income 2022 2 704 M - -
Net Debt 2022 11 505 M - -
P/E ratio 2022 22,4x
Yield 2022 1,73%
Capitalization 65 973 M 65 973 M -
EV / Sales 2021 4,06x
EV / Sales 2022 4,01x
Nbr of Employees 72 000
Free-Float 79,4%
More Financials
Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (52.4%): surgical instruments (71.6% of net sales), pharmaceutical systems (16.2%), and diabetes care products (12.2%); - diagnostic materials (24.9%): automated systems for blood testing, mycobacteria... 
More about the company
Notations Surperformance© of Becton, Dickinson and Company
Trading Rating : Investor Rating :
More Ratings
All news about BECTON, DICKINSON AND COMPANY
11/25BECTON DICKINSON AND : & CO Management's Discussion and Analysis of Financial Co..
AQ
11/25BECTON DICKINSON AND : Dickinson - BD Board Increases Dividend
AQ
11/24BECTON DICKINSON AND : Raises Dividend to 83 Cents
DJ
11/24BECTON DICKINSON AND : BD Board Increases Dividend
PR
11/24BECTON DICKINSON AND : BD Announces Streamlined Reporting Capabilities for COVID..
AQ
11/23BECTON DICKINSON AND : BD Announces Streamlined Reporting Capabilities for COVID..
PR
11/20BECTON DICKINSON AND : BD to Present at Evercore ISI 3rd Annual HealthCONx Virtu..
AQ
11/19BECTON DICKINSON AND : BD to Present at Evercore ISI 3rd Annual HealthCONx Virtu..
PR
11/17BECTON DICKINSON & CO : Change in Directors or Principal Officers (form 8-K)
AQ
11/14ELON MUSK : Elon Musk Says He Tested Positive for Covid-19 -- 7th Update
DJ
11/14ELON MUSK : Elon Musk Says He Tested Positive for Covid-19 -- 6th Update
DJ
11/13ELON MUSK : Tesla CEO Says He Tests Both Positive and Negative -- 4th Update
DJ
11/13ELON MUSK'S COVID-19 TESTS : Tesla CEO Says He Tests Both Positive and Negative ..
DJ
11/13ELON MUSK'S COVID-19 TESTS : Tesla CEO Says He Tests Both Positive and Negative ..
DJ
11/13ELON MUSK : Musk questions coronavirus tests, saying they gave opposite results ..
RE
More news
News in other languages on BECTON, DICKINSON AND COMPANY
11/13TESLA : Elon Musk a passé quatre tests Covid-19, dont deux positifs !
11/02BECTON, DICKINSON AND COMPANY : publication des résultats annuels
11/02BECTON, DICKINSON AND COMPANY : Veröffentlichung des Jahresergebnisses
08/03BECTON, DICKINSON AND COMPANY : publication des résultats trimestriels
08/03BECTON, DICKINSON AND COMPANY : Veröffentlichung des Quartalsergebnisses
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 274,50 $
Last Close Price 227,47 $
Spread / Highest target 31,9%
Spread / Average Target 20,7%
Spread / Lowest Target 12,1%
EPS Revisions
Managers
NameTitle
Thomas E. Polen President, Chief Executive Officer & Director
Vincent A. Forlenza Executive Chairman
Christopher R. Reidy EVP, Chief Financial & Administrative Officer
John A. DeFord Chief Technology Officer & Executive VP
William R. Sigmund Chief Medical Officer & EVP
Sector and Competitors
1st jan.Capitalization (M$)
BECTON, DICKINSON AND COMPANY-16.36%65 973
ABBOTT LABORATORIES22.51%188 597
MEDTRONIC PLC-0.12%151 957
HOYA CORPORATION32.49%49 699
BAXTER INTERNATIONAL INC.-9.84%38 511
ALIGN TECHNOLOGY, INC.69.76%37 351